학술논문

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, July 2024, 73(7))
Subject
Language
English
ISSN
14320851
03407004